A first-in-human phase 1a study of the bispecific...

  • Main
  • 2018 / 9
  • A first-in-human phase 1a study of the bispecific...
Investigational New Drugs 2018 / 9

A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors

Jimeno, Antonio, Moore, Kathleen N., Gordon, Michael, Chugh, Rashmi, Diamond, Jennifer R., Aljumaily, Raid, Mendelson, David, Kapoun, Ann M., Xu, Lu, Stagg, Robert, Smith, David C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0665-y
Date:
September, 2018
File:
PDF, 1.71 MB
english, 2018
Conversion to is in progress
Conversion to is failed